Year: 2026
Type: article
Abstract: Natural bioactive agents include flavonoids, mitochondrial-targeted antioxidants, and NAD+ precursors are under growing investigation as well as synthetic agents like dasatinib and rapamycin as promising senotherapeutics due to their ability to control these hallmarks. This broad overview incorporates the mechanistic understanding of the action of both plant-derived and synthetic agents on major aging processes and, in particular, the pharmacodynamics and pharmacokinetics of their actions in aging (or senescence) physiology. The changes in the performance of the CYP450 enzymes, tissue distributions, renal and hepatic clearance as well as gut microbiome composition with age significantly alter the ADMET profile of these agents, which affects the efficacy and safety of these agents. We critically review translational barriers, uncover gaps in age-relevant preclinical models, and suggest strategic solutions on how best to streamline senotherapeutic dosing and delivery system. Through a synthesis of the views of pharmacognosy, molecular geroscience, and translational pharmacology, this synthesis offers a holistic approach to safe and effective interventions that can lengthen healthspan in aging people.
Institution: D.Y. Patil Education Society
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7155055736
